...
机译:Arbitration Board Setting Reimbursement Amounts for Pharmaceutical Innovations in Germany When Price Negations between Payers and Manufacturers Fail: An Empirical Analysis of 5 Years' Experience
Univ Cologne, Cologne Inst Hlth Econ & Clin Epidemiol, Cologne, Germany;
Heinrich Heine Univ Dusseldorf, Fac Med, Inst Hlth Serv Res & Hlth Econ, Gebaude 14-82,Moorenstr 5;
AMNOG; arbitration board; early benefit assessment; price negotiations; reimbursement amount;